1. Home
  2. TLX vs CALM Comparison

TLX vs CALM Comparison

Compare TLX & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • CALM
  • Stock Information
  • Founded
  • TLX 2015
  • CALM 1957
  • Country
  • TLX Australia
  • CALM United States
  • Employees
  • TLX N/A
  • CALM N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • CALM Farming/Seeds/Milling
  • Sector
  • TLX Health Care
  • CALM Consumer Staples
  • Exchange
  • TLX Nasdaq
  • CALM Nasdaq
  • Market Cap
  • TLX 5.7B
  • CALM 4.9B
  • IPO Year
  • TLX N/A
  • CALM 1996
  • Fundamental
  • Price
  • TLX $11.53
  • CALM $107.54
  • Analyst Decision
  • TLX Strong Buy
  • CALM Hold
  • Analyst Count
  • TLX 3
  • CALM 2
  • Target Price
  • TLX $22.33
  • CALM $110.00
  • AVG Volume (30 Days)
  • TLX 64.4K
  • CALM 1.1M
  • Earning Date
  • TLX 01-01-0001
  • CALM 09-30-2025
  • Dividend Yield
  • TLX N/A
  • CALM 7.90%
  • EPS Growth
  • TLX 798.14
  • CALM 338.49
  • EPS
  • TLX 0.09
  • CALM 24.95
  • Revenue
  • TLX $484,687,790.00
  • CALM $4,261,885,000.00
  • Revenue This Year
  • TLX N/A
  • CALM N/A
  • Revenue Next Year
  • TLX N/A
  • CALM N/A
  • P/E Ratio
  • TLX $131.64
  • CALM $4.24
  • Revenue Growth
  • TLX 55.85
  • CALM 83.19
  • 52 Week Low
  • TLX $11.70
  • CALM $68.22
  • 52 Week High
  • TLX $30.36
  • CALM $126.40
  • Technical
  • Relative Strength Index (RSI)
  • TLX N/A
  • CALM 53.40
  • Support Level
  • TLX N/A
  • CALM $103.42
  • Resistance Level
  • TLX N/A
  • CALM $112.25
  • Average True Range (ATR)
  • TLX 0.00
  • CALM 4.74
  • MACD
  • TLX 0.00
  • CALM -0.50
  • Stochastic Oscillator
  • TLX 0.00
  • CALM 21.11

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

Share on Social Networks: